Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Monday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 2.9 % NASDAQ:EVOK opened at $1.32 on Monday. The company has a debt-to-equity ratio of 9.29, a current ratio of 3.50 […]